TY  - JOUR

T1  - Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS‐TIMI 54 Trial

JO  - Journal of the American Heart Association

PY  - 2020/05/18

AU  - Furtado RHM

AU  - Venkateswaran RV

AU  - Nicolau JC

AU  - Gurmu Y

AU  - Bhatt DL

AU  - Storey RF

AU  - Steg PG

AU  - Magnani G

AU  - Goto S

AU  - Dellborg M

AU  - Kamensky G et al

ED  - 

DO  - DOI: 10.1161/jaha.119.015785

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 9

IS  - 10

Y2  - 2024/12/22

ER  -